Hong-Jun Yeh, PhD, is MicroMED’s Chief Operating Officer. Dr Yeh focuses on business strategic planning, client/partner development, leading and managing programmes and teams in drug/device combination product commercialisation and life cycle management through the integration of biologics process development, drug delivery device R&D, overall manufacturing processes and business development. Dr Yeh has 30+ years
(post-PhD) of diversified experience across R&D, manufacturing, supplier/CMO/quality/risk management, programme management, and business development in the consumer products and biopharma/medical device industries at places like EWI, Baxter, J&J, Amgen Inc. (16+ years) and EirGenix.